Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 1376

1.

Before Freezing Out Cryobiopsy We Need to Thaw Out Flaws in the Diagnosis of ILD.

Maldonado F, Wells A, Danoff S, Colby T, Ryu J, Poletti V, Rickman O, Herth F, Wahidi M, Hetzel J, Liberman M, Yarmus LB.

Am J Respir Crit Care Med. 2019 Aug 23. doi: 10.1164/rccm.201903-0699LE. [Epub ahead of print] No abstract available.

PMID:
31442071
2.

Support for Breastfeeding Employees: Assessing Statewide Worksite Lactation Support Recognition Initiatives in the United States.

Reat A, Matthews KJ, Carver AE, Perez CA, Stagg J, Byrd-Williams CE.

J Hum Lact. 2019 Aug 22:890334419865902. doi: 10.1177/0890334419865902. [Epub ahead of print]

PMID:
31437403
3.

The Immune Landscape of Cancer.

Thorsson V, Gibbs DL, Brown SD, Wolf D, Bortone DS, Ou Yang TH, Porta-Pardo E, Gao GF, Plaisier CL, Eddy JA, Ziv E, Culhane AC, Paull EO, Sivakumar IKA, Gentles AJ, Malhotra R, Farshidfar F, Colaprico A, Parker JS, Mose LE, Vo NS, Liu J, Liu Y, Rader J, Dhankani V, Reynolds SM, Bowlby R, Califano A, Cherniack AD, Anastassiou D, Bedognetti D, Mokrab Y, Newman AM, Rao A, Chen K, Krasnitz A, Hu H, Malta TM, Noushmehr H, Pedamallu CS, Bullman S, Ojesina AI, Lamb A, Zhou W, Shen H, Choueiri TK, Weinstein JN, Guinney J, Saltz J, Holt RA, Rabkin CS; Cancer Genome Atlas Research Network, Lazar AJ, Serody JS, Demicco EG, Disis ML, Vincent BG, Shmulevich I.

Immunity. 2019 Aug 20;51(2):411-412. doi: 10.1016/j.immuni.2019.08.004. No abstract available.

PMID:
31433971
4.

The Inability of the Choroid to Revascularize in Oxygen-Induced Retinopathy Results from Increased P53/mir-Let-7b Activity.

Zhou TE, Zhu T, Rivera JC, Omri S, Tahiri H, Lahaie I, Rouget R, Wirth M, Nattel S, Lodygensky G, Ferbeyre G, Nezhady M, Desjarlais M, Hamel P, Chemtob S.

Am J Pathol. 2019 Aug 17. pii: S0002-9440(19)30665-0. doi: 10.1016/j.ajpath.2019.07.009. [Epub ahead of print]

PMID:
31430465
5.

Pathologic complete response and outcomes by intrinsic subtypes in NSABP B-41, a randomized neoadjuvant trial of chemotherapy with trastuzumab, lapatinib, or the combination.

Swain SM, Tang G, Lucas PC, Robidoux A, Goerlitz D, Harris BT, Bandos H, Geyer CE Jr, Rastogi P, Mamounas EP, Wolmark N.

Breast Cancer Res Treat. 2019 Aug 19. doi: 10.1007/s10549-019-05398-3. [Epub ahead of print]

PMID:
31428908
6.

A 25-year Period Analysis of Other-cause Mortality in Localized Prostate Cancer.

Knipper S, Pecoraro A, Palumbo C, Rosiello G, Luzzago S, Tian Z, Briganti A, Saad F, Tilki D, Graefen M, Karakiewicz PI.

Clin Genitourin Cancer. 2019 Jul 19. pii: S1558-7673(19)30224-1. doi: 10.1016/j.clgc.2019.07.008. [Epub ahead of print]

PMID:
31416752
7.

Adenosine A2a receptor promotes lymphangiogenesis and lymph node metastasis.

Allard B, Cousineau I, Allard D, Buisseret L, Pommey S, Chrobak P, Stagg J.

Oncoimmunology. 2019 Apr 26;8(8):1601481. doi: 10.1080/2162402X.2019.1601481. eCollection 2019.

PMID:
31413909
8.

The Effect of Lymph Node Dissection in Metastatic Prostate Cancer Patients Treated with Radical Prostatectomy: A Contemporary Analysis of Survival and Early Postoperative Outcomes.

Mazzone E, Preisser F, Nazzani S, Tian Z, Bandini M, Gandaglia G, Fossati N, Montorsi F, Graefen M, Shariat SF, Saad F, Briganti A, Karakiewicz PI.

Eur Urol Oncol. 2018 Nov 22. pii: S2588-9311(18)30191-3. doi: 10.1016/j.euo.2018.10.010. [Epub ahead of print]

PMID:
31411992
9.

Development and Validation of a Lookup Table for the Prediction of Metastatic Prostate Cancer According to Prostatic-specific Antigen Value, Clinical Tumor Stage, and Gleason Grade Groups.

Preisser F, Bandini M, Nazzani S, Mazzone E, Marchioni M, Tian Z, Chun FKH, Saad F, Briganti A, Haese A, Montorsi F, Huland H, Graefen M, Tilki D, Karakiewicz PI.

Eur Urol Oncol. 2019 Mar 28. pii: S2588-9311(19)30035-5. doi: 10.1016/j.euo.2019.03.003. [Epub ahead of print]

PMID:
31411975
10.

Contemporary Incidence and Mortality Rates in Patients With Testicular Germ Cell Tumors.

Palumbo C, Mistretta FA, Mazzone E, Knipper S, Tian Z, Perrotte P, Antonelli A, Montorsi F, Shariat SF, Saad F, Simeone C, Briganti A, Lattouf JB, Karakiewicz PI.

Clin Genitourin Cancer. 2019 Jun 13. pii: S1558-7673(19)30196-X. doi: 10.1016/j.clgc.2019.06.003. [Epub ahead of print]

PMID:
31378580
11.

Comparison of Open Versus Robotically Assisted Cytoreductive Radical Prostatectomy for Metastatic Prostate Cancer.

Preisser F, Nazzani S, Mazzone E, Marchioni M, Bandini M, Tian Z, Haese A, Saad F, Zorn K, Montorsi F, Shariat SF, Graefen M, Tilki D, Karakiewicz PI.

Clin Genitourin Cancer. 2019 May 27. pii: S1558-7673(19)30160-0. doi: 10.1016/j.clgc.2019.05.022. [Epub ahead of print]

PMID:
31375352
12.

Survival and Complication Rates of Metastasectomy in Patients With Metastatic Renal Cell Carcinoma Treated Exclusively With Targeted Therapy: A Combined Population-based Analysis.

Palumbo C, Pecoraro A, Knipper S, Rosiello G, Tian Z, Shariat SF, Simeone C, Briganti A, Saad F, Berruti A, Antonelli A, Karakiewicz PI.

Anticancer Res. 2019 Aug;39(8):4357-4361. doi: 10.21873/anticanres.13604.

PMID:
31366530
13.

Designable nanoplasmonic biomarkers for direct microscopy cytopathology diagnostics.

Wang L, Darviot C, Zapata-Farfan J, Patskovsky S, Trudel D, Meunier M.

J Biophotonics. 2019 Jul 31:e201900166. doi: 10.1002/jbio.201900166. [Epub ahead of print]

PMID:
31365187
14.

Management algorithms for prostate-specific antigen progression in prostate cancer: Biochemical recurrence after definitive therapy and progression to non-metastatic castrate-resistant prostate cancer.

Danielson B, Saad F, So A, Morgan S, Hamilton RJ, Malone S, Park-Wyllie L, Zardan A, Shayegan B.

Can Urol Assoc J. 2019 Feb 7. doi: 10.5489/cuaj.5600. [Epub ahead of print] Review.

PMID:
31364976
15.

Bone-targeted therapy in castration-resistant prostate cancer: where do we stand?

Gómez Rivas J, Carrion DM, Alvarez-Maestro M, Cathelineau X, Sanchez-Salas R, Di Lorenzo G, Di Maio M, Paul A, Martinez-Piñeiro L, Sartor O, Saad F, Debruyne F.

Minerva Urol Nefrol. 2019 Jul 25. doi: 10.23736/S0393-2249.19.03420-9. [Epub ahead of print]

PMID:
31353876
16.

2019 Canadian Urological Association (CUA)-Canadian Uro Oncology Group (CUOG) guidelines for the management of castration-resistant prostate cancer (CRPC).

Saad F, Aprikian A, Finelli A, Fleshner NE, Gleave M, Kapoor A, Niazi T, North S, Pouliot F, Rendon R, Shayegan B, Sridhar S, So A, Usmani N, Vigneault E, Chi KN.

Can Urol Assoc J. 2019 Jun 25. doi: 10.5489/cuaj.6136. [Epub ahead of print] No abstract available.

PMID:
31348741
17.

In Non-Metastatic pT1b Kidney Cancer Patients Cryoablation Predisposes to Higher Cancer Specific Mortality Relative to Partial Nephrectomy.

Pecoraro A, Palumbo C, Knipper S, Mistretta FA, Tian Z, Shariat SF, Saad F, Briganti A, Fiori C, Porpiglia F, Karakiewicz PI.

J Urol. 2019 Jul 26:101097JU0000000000000460. doi: 10.1097/JU.0000000000000460. [Epub ahead of print]

PMID:
31347950
18.

Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial.

de Boer SM, Powell ME, Mileshkin L, Katsaros D, Bessette P, Haie-Meder C, Ottevanger PB, Ledermann JA, Khaw P, D'Amico R, Fyles A, Baron MH, Jürgenliemk-Schulz IM, Kitchener HC, Nijman HW, Wilson G, Brooks S, Gribaudo S, Provencher D, Hanzen C, Kruitwagen RF, Smit VTHBM, Singh N, Do V, Lissoni A, Nout RA, Feeney A, Verhoeven-Adema KW, Putter H, Creutzberg CL; PORTEC Study Group.

Lancet Oncol. 2019 Jul 22. pii: S1470-2045(19)30395-X. doi: 10.1016/S1470-2045(19)30395-X. [Epub ahead of print]

19.

Impact of Obesity on Perioperative Outcomes at Robotic-assisted and Open Radical Prostatectomy: Results From the National Inpatient Sample.

Knipper S, Mazzone E, Mistretta FA, Palumbo C, Tian Z, Briganti A, Saad F, Tilki D, Graefen M, Karakiewicz PI.

Urology. 2019 Jul 20. pii: S0090-4295(19)30646-6. doi: 10.1016/j.urology.2019.05.053. [Epub ahead of print]

PMID:
31336110
20.

Nodular Regenerative Hyperplasia: Expression Pattern of Glutamine Synthetase and a Potential Role for Hepatic Progenitor Cells.

Guilbert MC, Therrien A, Soucy G, Trudel D, Nguyen BN.

Appl Immunohistochem Mol Morphol. 2019 Jul 18. doi: 10.1097/PAI.0000000000000793. [Epub ahead of print]

PMID:
31335486

Supplemental Content

Loading ...
Support Center